Jonathan P. Mow

2018

In 2018, Jonathan P. Mow earned a total compensation of $595.6K as Chief Executive Officer at PhaseBio Pharmaceuticals, a 37% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$201,300
Option Awards$34,531
Salary$358,971
Other$828
Total$595,630

Mow received $359K in salary, accounting for 60% of the total pay in 2018.

Mow also received $201.3K in non-equity incentive plan, $34.5K in option awards and $828 in other compensation.

Rankings

In 2018, Jonathan P. Mow's compensation ranked 11,305th out of 14,244 executives tracked by ExecPay. In other words, Mow earned more than 20.6% of executives.

ClassificationRankingPercentile
All
11,305
out of 14,244
21st
Division
Manufacturing
4,575
out of 5,765
21st
Major group
Chemicals And Allied Products
1,735
out of 2,128
19th
Industry group
Drugs
1,474
out of 1,817
19th
Industry
Pharmaceutical Preparations
1,131
out of 1,391
19th
Source: SEC filing on April 5, 2019.

Mow's colleagues

We found three more compensation records of executives who worked with Jonathan P. Mow at PhaseBio Pharmaceuticals in 2018.

2018

John Lee

PhaseBio Pharmaceuticals

Chief Medical Officer

2018

John Sharp

PhaseBio Pharmaceuticals

Chief Financial Officer

2018

John Sharp

PhaseBio Pharmaceuticals

Chief Financial Officer

News

You may also like